Literature DB >> 6421789

A macrocyclic antibiotic M-230B produced by Myxococcus xanthus. Isolation and characterization.

N Onishi, K Izaki, H Takahashi.   

Abstract

Myxococcus xanthus strain M516E produced at least three related antibiotics against Gram-positive and Gram-negative bacteria. From physico-chemical properties, a main component was identical to myxovirescin A and a second component, designated M-230B was found to be an antibiotic which is closely related to myxovirescin A. The structure of M-230B was determined from its physico-chemical properties, especially from 13C NMR spectrum as compared with that of myxovirescin A. The addition of alcohol, such as isobutyl alcohol, to the culture medium markedly stimulated production of the antibiotics.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421789     DOI: 10.7164/antibiotics.37.13

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.

Authors:  Yao Xiao; Daniel Wall
Journal:  J Bacteriol       Date:  2014-01-03       Impact factor: 3.490

2.  Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.

Authors:  Yao Xiao; Klaus Gerth; Rolf Müller; Daniel Wall
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

3.  Transfer of plasmid RP4 to Myxococcus xanthus and evidence for its integration into the chromosome.

Authors:  A M Breton; S Jaoua; J Guespin-Michel
Journal:  J Bacteriol       Date:  1985-02       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.